| 词条 | Nacolomab tafenatox |
| 释义 |
| Verifiedfields = changed | verifiedrevid = 458284622 | image = | type = mab | mab_type = Fab | source = o | target = colorectal tumor antigen C242 | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = none | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 150631-27-9 | ATC_prefix = none | ATC_suffix = | PubChem = | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | chemical_formula = | molecular_weight = }}Nacolomab tafenatox is a mouse monoclonal antibody[1] designed for the treatment of colorectal cancer.{{Citation needed|date=October 2009}} The antibody itself, nacolomab, is fused with enterotoxin A from Staphylococcus aureus (which is reflected by 'tafenatox' in the drug's name).[1] See also
References1. ^1 WHO Drug Information {{Monoclonals for tumors}}{{DEFAULTSORT:Nacolomab Tafenatox}}{{monoclonal-antibody-stub}}{{antineoplastic-drug-stub}} 1 : Monoclonal antibodies for tumors |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。